# Genetic Pathology * **Definition:** Genetic Pathology is a branch of pathology that focuses on the study and diagnosis of diseases caused by genetic abnormalities, including inherited disorders and mutations, through the analysis of genetic material and its expression. * **Taxonomy:** Specialties / Genetic Pathology ## News * Selected news on the topic of **Genetic Pathology**, for healthcare technology leaders * 4.7K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/28/2024 | [**Artificial Intelligence - Healthcare IT News**](https://www.healthcareitnews.com/taxonomy/term/7341/m89gsv6dzcjz.jsp/page/2?type=video) | [[Healthcare IT News]] | | 12/11/2024 | [**Do AI Diagnostics have a role in telemedicine? What does this mean for healthcare equity?**](https://www.healthtechmagazines.com/do-ai-diagnostics-have-a-role-in-telemedicine-what-does-this-mean-for-healthcare-equity/) | [[Health Tech Magazines]] | | 12/7/2024 | [**Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27AGR - Report by S&S Insider**](https://finance.yahoo.com/news/genotyping-market-hit-usd-59-140000786.html) | [[Yahoo Finance]] | | 11/27/2024 | [**Patient Engagement Technology Market to grow by USD 37.41 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/patient-engagement-technology-market-to-grow-by-usd-37-41-billion-from-2024-2028--driven-by-rising-chronic-disease-cases-and-ais-impact-on-market-trends---technavio-302316647.html) | [[PR Newswire]] | | 11/26/2024 | [**Mount Sinai leans into AI with new research center - Healthcare Finance News**](https://www.healthcarefinancenews.com/news/mount-sinai-leans-ai-new-research-center) | [[Healthcare Finance]] | | 11/26/2024 | [**Mount Sinai Center to Combine AI, Data Science, Genomics - Healthcare Innovation**](https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/55246083/mount-sinai-center-to-combine-ai-data-science-genomics) | [[Healthcare Innovation]] | | 11/25/2024 | [**Mount Sinai Health announces new Center for AI and Human Health - Healthcare IT News**](https://www.healthcareitnews.com/news/mount-sinai-health-announces-new-center-ai-and-human-health) | [[Healthcare IT News]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage (London ...**](https://www.marketwatch.com/press-release/digi-tech-pharma-ai-conference-2025-ai-and-genomics-take-center-stage-london-united-kingdom-may-28-29-2025-researchandmarkets-com-2a20b074) | [[MarketWatch]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/11/2024 | [**Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/population-health-management-market-to-grow-by-usd-22-55-billion-from-2024-2028--driven-by-rising-adoption-of-healthcare-it-report-with-ai-impact-on-trends---technavio-302300769.html) | [[PR Newswire]] | | 11/8/2024 | [**AI-driven precision healthcare is here - what you need to know**](https://www.healthcareitnews.com/news/ai-driven-precision-healthcare-here-what-you-need-know) | [[Healthcare IT News]] | | 11/7/2024 | [**Next-Generation Sequencing (NGS) Services Market is expected to generate a revenue of ...**](https://www.prnewswire.com/news-releases/next-generation-sequencing-ngs-services-market-is-expected-to-generate-a-revenue-of-usd-18-35-billion-by-2031--globally-at-21-25-cagr-verified-market-research-302298672.html) | [[PR Newswire]] | | 10/16/2024 | [**AI in Healthcare: Transforming Diagnosis and Treatment**](https://healthcareguys.com/2024/10/16/ai-in-healthcare-transforming-diagnosis-and-treatment/?utm_source=rss&utm_medium=rss&utm_campaign=ai-in-healthcare-transforming-diagnosis-and-treatment) | [[The Healthcare Guys]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.morningstar.com/news/business-wire/20241008712158/seqster-ceo-ardy-arianpour-named-to-pharmavoice-100-for-innovation-in-life-sciences-for-a-second-consecutive-year) | [[Morningstar]] | | 10/7/2024 | [**Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia's ... - Morningstar**](https://www.morningstar.com/news/globe-newswire/1000995993/siloam-hospitals-group-and-philips-sign-ai-capability-mou-to-support-indonesias-healthcare-transformation-strategy) | [[Morningstar]] | | 10/7/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](https://www.businesswire.com/news/home/20241008712158/en/) | [[Business Wire]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 7/22/2024 | [**Robert T. Braithwaite, Channing Hamlet and Daniel A. Platt Share Insights on ... - Los Angeles Times**](https://www.latimes.com/business-insights/story/2024-07-22/robert-t-braithwaite-channing-hamlet-and-daniel-a-platt-share-insights-on-the-healthcare-biotech-and-life-sciences-landscape-in-2024) | [[LA Times]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **GeneDx**: A genomics company that conducts research on genetic diagnoses and disparities in access to genetic testing. - **Myriad Genetics, Inc.**: A leader in genetic testing, focusing on oncology, women's health, and pharmacogenomics, with significant investments in labs and digital capabilities. - **Genome Medical**: Enhances the identification of clinical trial patients for ultra-rare diseases using clinical-grade data. - **Labcorp**: A laboratory services provider that is expanding its genetic testing capabilities through strategic collaborations. - **Myriad Genetics**: A genetic testing company that partnered with Flatiron Health to integrate its MyRisk Hereditary Cancer Test into oncology workflows. - **Paige**: A company specializing in AI-driven pathology solutions to improve diagnostics and treatment. - **Genomics plc**: A company focused on leveraging genetics in healthcare, recently appointing David Thornton as President to enhance operations. - **Cofactor Genomics, Inc.**: A clinical-stage diagnostics company focused on bridging the precision medicine gap by decoding RNA to enhance understanding of health and disease. - **Ambry Genetics**: A company specializing in hereditary cancer screening, which is being acquired by Tempus to enhance its testing capabilities. - **Children's National**: A pediatric healthcare organization leveraging AI for genetic condition screening and improving healthcare in resource-limited countries. - **Guardant Health, Inc.**: A company specializing in advanced blood and tissue tests for cancer care, focusing on tumor profiling and ctDNA monitoring. - **Genoks**: A Turkish genomics healthcare company partnering with Velsera to enhance cancer diagnostics. - **Saphetor SA**: Provider of the VarSome Clinical platform, which automates the interpretation of Next Generation Sequencing (NGS) data. - **BioAI**: A company collaborating with Genomic Testing Cooperative to enhance biomarker discovery and diagnostics using multimodal artificial intelligence. - **Illumina**: A company that has significantly reduced the cost of genome sequencing, enhancing genetic variation and biological function analysis. - **Tempus AI, Inc.**: A genomics and data services company that recently announced the acquisition of Ambry Genetics to enhance its testing capabilities. - **Clarapath**: A medical robotics company specializing in automating pathology laboratory processes. - **Alpenglow Biosciences**: A company focused on advancing clinical product development in 3D spatial biology, particularly in precision tumor removal technology. - **Codoxo**: A company specializing in AI-powered platforms for healthcare cost management and fraud detection in genetic testing. ### Partnerships and Collaborations - **GeneDx and various institutions**: GeneDx collaborated on a study addressing racial disparities in genetic diagnoses, emphasizing the need for equitable access to testing. - **Epic and GeneDx**: Integrating rapid whole genome sequencing technology into Epic's EHR system for improved genomic insights. - **Singapore National Precision Medicine Program and Oxford Nanopore**: A program aimed at sequencing 10,000 genomes to understand local genetic diversity. - **Labcorp and Ultima Genomics**: Partnership to utilize advanced sequencing technology for clinical applications in whole genome sequencing. - **Myriad Genetics and GSK/QIAGEN**: Strategic partnerships to enhance capabilities in HRD diagnostic testing. - **BioAI and Genomic Testing Cooperative**: This partnership aims to enhance biomarker discovery and diagnostics through AI, creating genomic biomarker screening algorithms. - **Eli Lilly and Genetic Leap**: Collaborating to develop genetic medicine therapeutics using RNA-targeted AI technology. - **Alpenglow and CorePlus**: Collaboration to develop AI-driven 3D pathology tests for prostate cancer diagnostics. - **Principle Health Systems and Telos PGX**: Acquisition aimed at enhancing personalized medication solutions through advanced pharmacogenetic testing. - **Myriad Genetics and Flatiron Health**: Integration of MyRisk test into Flatiron's OncoEMR platform to streamline cancer care. - **Genoks and Velsera**: A partnership to integrate Velsera's Clinical Genomics Workspace into Genoks' cancer diagnostic services. - **Tempus and Ambry Genetics**: Tempus is acquiring Ambry Genetics for $600 million to enhance its genetic testing capabilities and expand disease coverage. - **Texas A&M Health and BurstIQ**: Partnering to utilize the LifeGraph management platform for genomic data governance. - **AGFA HealthCare and Corista**: Collaboration to launch Enterprise Imaging for Pathology, enhancing digital workflows. - **Labcorp and Ballad Health**: Strategic collaboration to enhance outreach laboratory services in the Appalachian Highlands. - **Mount Sinai and Hasso Plattner Institute**: Collaboration aimed at enhancing capabilities in data science and AI, focusing on genomic health and personalized medicine. - **Guardant Health and Meaningful Insights Biotech Analytics (MiBA)**: This collaboration focuses on improving precision medicine through enhanced biomarker testing and data analytics. - **Roche and AI Collaborators**: Integration of AI algorithms from multiple collaborators to enhance cancer diagnostics. - **Microsoft and Providence/Paige.ai**: Collaborating to develop multimodal medical imaging foundation models for healthcare data analysis. - **Paige and UK Hospital Systems**: Evaluation of Paige's AI technology for prostate cancer diagnosis in clinical settings. ### Innovations, Trends, and Initiatives - **AI in Genetic Pathology**: AI tools are enhancing personalized medicine by analyzing patient data to create tailored treatment plans, particularly for complex diseases. - **Precision Medicine**: A transformative approach utilizing individual genetic, environmental, and lifestyle factors to enhance patient outcomes. - **Hyper-personalized Medicine**: An approach tailoring treatments based on genetic makeup, environment, and lifestyle, driven by advancements in genomics and data analytics. - **AI in Genetic Testing**: AI-driven diagnostics are facilitating precise analysis of genetic data, enabling early intervention and targeted therapies. - **Whole Genome and Exome Sequencing Market**: Projected to grow significantly, reflecting the demand for personalized medicine and the prevalence of genetic disorders. - **Whole-Exome Sequencing (WES)**: Increasingly used in clinical diagnostics to identify genetic factors affecting diseases, driven by advancements in AI and bioinformatics. - **Digital Pathology Solutions**: The market for digital pathology is projected to grow significantly, driven by advancements in AI and machine learning, improving diagnostic precision. - **Personalized Medicine**: The healthcare industry is moving towards personalized medicine, driven by genetic testing and data integration. - **VarSome Clinical Platform**: Automates the discovery and interpretation of NGS data, reflecting advancements in clinical genomics. - **Next-Generation Sequencing**: Technological advancements improving accuracy and efficiency in DNA sequencing, facilitating personalized medicine. - **AI in Pathology**: The use of AI technologies like Paige Alba to assist pathologists in diagnostics and treatment. - **Generative AI in Science**: Transforming research by enabling complex problem-solving and accelerating discoveries in genomics and drug development. - **Next-Generation Sequencing (NGS) Services Market**: Projected to grow significantly due to advancements in precision medicine and genomics, enhancing diagnostics and personalized treatment. - **AI-Driven Personalized Medicine**: AI is enabling the creation of individualized treatment plans based on genetic information and patient data. - **Precision Medicine Software Market Growth**: Projected to grow significantly, driven by advancements in genomics and increasing demand for personalized healthcare solutions. - **AI in Genomics**: The market for AI in genomics is projected to grow significantly, enhancing drug discovery and personalized medicine applications. - **3D Spatial Biology**: Emerging technology that enhances tumor margin identification and precision in cancer treatment. - **Thermal Cyclers Market Growth**: The thermal cyclers market is expected to grow due to increasing demand for molecular biology and genetic analysis, with innovations in technology enhancing efficiency. ### Challenges and Concerns - **Access Disparities**: Despite similar diagnostic yields, systemic barriers prevent equitable access to genetic testing, particularly for non-white populations. - **Regulatory Compliance**: The integration of genetic testing into healthcare raises concerns about compliance with regulations and maintaining consumer trust. - **Data Security**: Concerns about the security and potential re-identification of de-identified data in genetic testing. - **High Costs of Precision Medicine**: Challenges related to the affordability of precision medicine and the need for interdisciplinary collaboration. - **Data Privacy**: Concerns regarding the security and privacy of genomic data as AI technologies become more integrated into healthcare. - **Training Needs**: Extensive training is required for healthcare professionals to effectively utilize new AI and genomic technologies. - **Regulatory Issues**: The heavily regulated nature of the biopharma industry poses barriers to the adoption of generative AI. - **Ethical Implications of AI**: Concerns regarding the safety and ethical use of AI technologies in healthcare, particularly in diagnostics. - **Algorithmic Bias**: The need for transparency and fairness in AI algorithms used for diagnostics. - **Data Fragmentation**: Fragmented healthcare data hinders advancements in patient care and personalized treatment interventions. - **Patient Privacy**: Ensuring patient privacy and informed consent while promoting responsible data sharing remains a challenge. - **Implementation Costs**: High costs and interoperability issues hinder the widespread adoption of precision medicine software in smaller healthcare institutions. - **Regulatory Hurdles**: Challenges such as regulatory restrictions and the need for human oversight in clinical decision-making are hindering broader AI deployment in medicine. - **Data Privacy and Security**: The DTC Wellness Testing Market faces challenges related to data privacy, necessitating robust protection measures. - **Integration of AI in Clinical Settings**: Challenges in ensuring safe and effective use of AI technologies in real-world applications. - **Ethical Considerations in AI**: The integration of AI in healthcare raises ethical issues, including data quality and the interpretability of AI models. - **Cybersecurity Concerns**: As AI technologies evolve, ensuring the security and privacy of patient data remains a significant concern. ## Related Topics [[Molecular Genetic Pathology]]; [[Clinical Genetics]]; [[Genetic Testing]]; [[Medical Genetics]]; [[Pediatric Pathology]]; [[Laboratory Genetics]]; [[Clinical Genomics]]; [[Biochemical Genetics]]; [[Clinical Pathology]]